Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A new method using nanolipogels with fucosterol can help regrow hair by targeting follicles, reducing inflammation, and improving blood flow.

Topical minoxidil may cause more side effects than currently listed, needing updated safety information.

Drug repurposing can create safer, cheaper treatments by finding new uses for existing drugs.

Minoxidil sulfate and pinacidil promote hair growth likely by increasing blood flow, not by activating K channels.

Drug repurposing finds new uses for old drugs quickly and cheaply.

A reliable method was developed to measure aristolochic acid-I in rat blood.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

A new, quick method accurately detects minoxidil in drugs and cosmetics.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Blocking allopregnanolone production in mice makes them more anxious after stress, but this can be reversed with a drug that mimics allopregnanolone.

Using minoxidil for hair loss might cause sudden vision loss, so use it with caution and monitor closely.

Serenoa repens is mostly safe but has some risks, especially at high doses or when used with other products for over two weeks.

Extended-release valproate effectively reduced seizures and improved quality of life in epilepsy patients over 6 months, with some side effects.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Midazolam reduces PTSD-like behavior in rats by acting on specific brain receptors.

Allopregnanolone may enhance alcohol's effects on dopamine neurons, influencing addiction risk.

Raman spectroscopy is promising for measuring and enhancing drug delivery in alopecia treatments.

Minoxidil didn't increase scalp blood flow for hair growth, but hexyl nicotinate did.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Sublingual and oral minoxidil are equally effective for hair growth, but sublingual causes fewer palpitations.

Minoxidil given intravenously caused small changes in diastolic blood pressure and increased heart rate at higher concentrations in patients with high blood pressure.

Blocking the KATP channel may help treat migraines.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Low-dose oral minoxidil doesn't affect blood pressure in patients taking blood pressure meds.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.